New drug ASKB589 tested against advanced cancers
NCT ID NCT04632108
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests an experimental drug called ASKB589 in about 199 people with advanced solid tumors that have spread. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. People with stomach or pancreatic cancer are especially wanted for this trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ASKB589 (an experimental drug given by injection)
What this could lead to
If it works, this could point toward a new treatment option for people with advanced solid tumors, especially gastric and pancreatic cancers.
What could go wrong
This is an early-phase trial (Phase 1/2) with only 199 participants, so the drug may not prove effective or safe enough for wider use. Side effects could be serious, including life-threatening events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing cancer hospital
Beijing, Beijing Municipality, 100089, China
-
Linyi cancer hospital
Linyi, Shandong, 276000, China